REPONEX PHARMACEUTICALS A/S: Financial statements 2020
CVR: 30082346
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
REPONEX PHARMACEUTICALS A/S (CVR 30082346) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK -1,504,899 compared with DKK -1,853,921 the year before. Equity in the 2020 report amounted to DKK 13,428,441. The solvency ratio was 65.8%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -1,504,899
- Equity
- DKK 13,428,441
- Total Assets
- DKK 20,408,871
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | 0 | -1.5 mio. | 13.4 mio. | - |
| 2019 | 0 | 0 | -1.9 mio. | 14.9 mio. | - |
| 2018 | 0 | 0 | -1.3 mio. | 2.4 mio. | - |
| 2017 | - | -1.3 mio. | -1.6 mio. | 3.7 mio. | - |
| 2016 | - | 242 t. | -332 t. | 5.2 mio. | - |
Official annual report
How creditworthy is REPONEX PHARMACEUTICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
REPONEX PHARMACEUTICALS A/S has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK -1,853,921.
About REPONEX PHARMACEUTICALS A/S
REPONEX PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPONEX PHARMACEUTICALS ApS and TRIFOILIUM ApS. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Troels Peter Troelsen and Charlotte Pahl. The company is owned by Pharma Equity Group A/S. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -6,570,000 compared with DKK -11,943,000 the year before. Equity in the 2025 report amounted to DKK 4,645,000.